Abstract
Background: Amidrazones have been reported to have significant anti-tumor properties against several cancer cell lines.
Objectives: The current project aims to profile the structure-anticancer activity relationship of phenyl-amidrazons.
Methods: Fifteen phenyl-amidrazone-piperazine derivatives were prepared and tested against four cancer cell lines (leukemia, prostate, breast and colon cancers).
Results: Six compounds illustrated low micromolar anticancer IC50 values, while the remaining compounds were either inactive or of moderate potencies. All compounds were virtually nontoxic against normal fibroblast cells.
Conclusion: Docking into the oncogenic kinase bcr/abl illustrated the critical importance of (i) phalogen substituent on the ligand's phenyl ring and (ii) the presence of positive ionizable moiety at the ligand's piperazine fragment for anticancer activity.
Keywords: Aryl-amidrazones, anticancer bioactivity, docking, SAR, electrostatic attraction, hydrogen bonding.
Medicinal Chemistry
Title:Synthesis and Structure-Activity Relationship; Exploration of some Potent Anti-Cancer Phenyl Amidrazone Derivatives
Volume: 14 Issue: 5
Author(s): Almeqdad Y. Habashneh, Mustafa M. El-Abadelah, Sanaa K. Bardaweel and Mutasem O. Taha*
Affiliation:
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, The University of Jordan, Amman,Jordan
Keywords: Aryl-amidrazones, anticancer bioactivity, docking, SAR, electrostatic attraction, hydrogen bonding.
Abstract: Background: Amidrazones have been reported to have significant anti-tumor properties against several cancer cell lines.
Objectives: The current project aims to profile the structure-anticancer activity relationship of phenyl-amidrazons.
Methods: Fifteen phenyl-amidrazone-piperazine derivatives were prepared and tested against four cancer cell lines (leukemia, prostate, breast and colon cancers).
Results: Six compounds illustrated low micromolar anticancer IC50 values, while the remaining compounds were either inactive or of moderate potencies. All compounds were virtually nontoxic against normal fibroblast cells.
Conclusion: Docking into the oncogenic kinase bcr/abl illustrated the critical importance of (i) phalogen substituent on the ligand's phenyl ring and (ii) the presence of positive ionizable moiety at the ligand's piperazine fragment for anticancer activity.
Export Options
About this article
Cite this article as:
Habashneh Y. Almeqdad , El-Abadelah M. Mustafa, Bardaweel K. Sanaa and Taha O. Mutasem*, Synthesis and Structure-Activity Relationship; Exploration of some Potent Anti-Cancer Phenyl Amidrazone Derivatives, Medicinal Chemistry 2018; 14 (5) . https://dx.doi.org/10.2174/1573406414666171204143157
DOI https://dx.doi.org/10.2174/1573406414666171204143157 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Approaches to Novel Antibacterials Designed After LPS Structure and Biochemistry
Current Drug Targets Editorial [ Hot topic: Pharmaceutical Design of Novel Anticancer Agents: A Lesson from Nature (Executive Editor: Q. Ping Dou)]
Current Pharmaceutical Design Biological Activities and In Silico Physico-Chemical Properties of 1,2,3- Triazoles Derived from Natural Bioactive Alcohols
Anti-Infective Agents Novel Diaryl or Heterocyclic Sulfonamides as Antimitotic Agents
Anti-Cancer Agents in Medicinal Chemistry Structure-Bioactivity Relationship Study of Xanthene Derivatives: A Brief Review
Current Organic Synthesis The First Approved Agent in the Glitazar’s Class: Saroglitazar
Current Drug Targets Impact of Traditional Plants and their Secondary Metabolites in the Discovery of COVID-19 Treatment
Current Pharmaceutical Design Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: The Case of Edaravone
Current Medicinal Chemistry Laparoscopic Approach to a Patient with Omental Infarction: A Case Report
New Emirates Medical Journal N-Methylated α-Amino Acids And Peptides: Synthesis And Biological Activity
Mini-Reviews in Medicinal Chemistry Chronic Systemic Low-Grade Inflammation and Modern Lifestyle: The Dark Role of Gut Microbiota on Related Diseases with a Focus on COVID-19 Pandemic
Current Medicinal Chemistry Antimalarial Drug Discovery: In Silico Structural Biology and Rational Drug Design
Infectious Disorders - Drug Targets NOS Inhibitors: Structure, Biological Activity and Mechanism of Action
Current Enzyme Inhibition Inflammatory Mechanisms in Myocardial Infarction
Current Drug Targets - Inflammation & Allergy Drug Discovery and Design for Complex Diseases through QSAR Computational Methods
Current Pharmaceutical Design The Recent Development of α<sub>7</sub> Nicotinic Acetylcholine Receptor (nAChR) Ligands as Therapeutic Candidates for the Treatment of Central Nervous System (CNS) Diseases
Current Pharmaceutical Design Novel Systemic Drugs for Cutaneous T-Cell Lymphoma
Recent Patents on Anti-Cancer Drug Discovery Multifunctional Lipoic Acid Conjugates
Current Medicinal Chemistry Biphenyl Amides and Isosteres as MCH R1 Antagonists
Current Topics in Medicinal Chemistry Bioanalytical and Biophysical Techniques for the Elucidation of the Mode of Action of Metal-Based Drugs
Current Topics in Medicinal Chemistry